ArticleFrontiers in physiology2026
Prediction of acute mountain sickness from overnight pulse oximetry during ascent to Everest Base Camp: a field-based machine learning study.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute mountain sickness (AMS) affects a large proportion of individuals ascending to high altitude every year. While AMS is not life threatening, if left untreated it can progress to serious illness (e.g., high altitude cerebral oedema). Current assessment tools rely on subjective symptom reporting and do not enable prospective prediction. Objective, field-deployable methods for early risk stratification remain limited. This study evaluated whether physiological biomarkers derived from overnight pulse oximetry can predict subsequent AMS during ascent to Everest Base Camp (EBC). Methods: A field study was conducted in the Khumbu region of Nepal. Healthy lowlanders (n = 139-144 across datasets) underwent overnight pulse oximetry recordings at Namche Bazaar (3,440 m) and Dingboche-level (4,371-4,730 m). A total of 125 physiological features were extracted from continuous, overnight oxygen saturation (SpO Results: Biomarker-only models demonstrated consistent above-chance discrimination at both altitudes (mean AUC 0.74 at both Namche and Dingboche-level). At lower altitude, predictive performance was achieved using a small set of physiological features, and inclusion of metadata did not improve model performance. At higher altitude, combining biomarkers with contextual variables improved discrimination (AUC 0.84 ± 0.08; sensitivity 0.73 ± 0.23). Selected features were primarily related to nocturnal oxygenation burden, desaturation dynamics, and heart rate variability. Conclusion: Overnight pulse oximetry captures physiological signals associated with subsequent AMS development prior to symptom onset. These findings support the feasibility of objective, non-invasive risk stratification during early ascent. Integration of wearable monitoring with computational modelling may provide a complementary tool to support preventative decision-making along high-altitude trekking routes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.